1. Yezhelyev MV, Gao X, Xing Y, Hajj AA,
Nie S and Regan RMO: Emerging use of
nanoparticles in diagnosis and treatment of
breast cancer Lancet Oncol. 2006; 7: 657–
667.
2. Wagner V, Dullaart A, Bock AK and
Zweck A: The emerging nanomedicin
landscape, Nat Biotechnol. 2006; 24: 1211–
1217.
3. Sahoo SK, Dilnawaz F and Krishnakumar
S: Nanotechnology in ocular drug delivery.
Drug Discov Today 2008; 13: 144–151.
4. Silver S, Phung LT and Silver G: Silver as
biocides in burn and wound dressings and
bacterial resistance to silver compounds, J
Ind Microbiol Biotechnol. 2006; 33: 627–
634.
5. Klasen HJ: Historical review of the use of
silver in the treatment of burns. I. Early
uses, Burns. 2000; 26: 117–130.
6. Arora S, Jain J, Rajwade JM and Paknikar
KM: Cellular responses induced by silver
nanoparticles: In vitro studies, Toxicol Lett.
2008; 179: 93–100.
7. Kumari A, Kumar P, Ajayan PM and John
G: Silver-nanoparticle-embedded
antimicrobial paints based on vegetable oil,
Nat Mater. 2008; 7: 236–241.
8. Dunn K and Edwards-Jones V: The role
of Acticoat with nanocrystalline silver in the
management of burns, Burns. 2004; 30: S1–
S9.
9. Bhattacharya R and Mukherjee P:
Biological properties of “naked” metal
nanoparticles, Adv Drug Deliv Rev. 2008; 60:
1289–1306.
10. Kalishwaralal K, BarathManiKanth S,
Pandian SRK, Deepak V and Gurunathan S:
Silver nano – a trove for retinal therapies. J
Control Release 2010; 29: [Epub ahead of
print].
11. Lara HH, Ayala-Nuñez NV, Ixtepan-
Turrent L and Rodriguez-Padilla C: Mode of
antiviral action of silver nanoparticles
against HIV-1, J Nanobiotechnology 2010; 8:
1.
12. Sun RW, Rong C, Chung NPY, Ho CM, Lin
CLS and Che CM: Silver nanoparticles
REFERENCES
Research Article ISSN: 2277-8713
Rayasa RM, IJPRBS, 2012; Volume 1(5): 160-177 IJPRBS
Available Online At www.ijprbs.com
fabricated in Hepes buffer exhibit
cytoprotective activities toward HIV-1
infected cells, Chem Commun (Camb) 2005;
28: 5059–5061.
13. Lu L, Sun RW, Chen R, et al.: Silver
nanoparticles inhibit hepatitis B virus
replication. Antivir Ther. 2008; 13: 253–262.
14. Sun L, Singh AK, Vig K, PillaiPR and Singh
SR: Silver nanoparticles inhibit replication of
respiratory syncytial virus, J Biomed
Biotechnol. 2008; 4: 149–158.
15. Baram-Pinto D, Shukla S, Perkas N,
Gedanken A and Sarid R: Inhibition of
herpes simplex virus type 1 infection by
silver nanoparticles capped with mercapto
ethane sulfonate, Bioconjug Chem. 2009;
20: 1497–1502.
16. Rogers JV, Parkinson CV, Choi YW,
Speshock JL and Hussain SM: A preliminary
assessment of silver nanoparticle inhibition
of monkeypox virus plaque formation,
Nanoscale Research Letters 2008; 3: 129–
133.
17. Hu R, Yong KT and Roy I: Metallic
nanostructures as localized plasmon
resonance enhanced scattering probes for
multiplex dark field targeted imaging of
cancer cells, J Phys Chem C Nanomater
Interfaces 2009; 113: 2676–2684.
18. Kemp MM, Kumar A and Mousa S:
Synthesis of gold and silver nanoparticles
stabilized with glycosaminoglycans having
distinctive biological activities.
Biomacromolecules 2009; 10: 589–595.
19. Kalishwaralal K, Banumathi E, Pandian
SBRK, Deepak V, Muniyandi J, Eom SH and
Sangiliyandi G: Silver nanoparticles inhibit
VEGF induced cell proliferation and
migration in bovine retinal endothelial cells.
Colloid Surf B: Bioint 2009; 73(1): 51-7.
20. Hussain SM, Hess KL, Gearhart JM, Geiss
KT and Schlager JJ: In vitro toxicity of
nanoparticles in BRL 3A rat liver cells,
Toxicology in vitro 2005; 19(7): 975–983.,
21. Jain J, Arora S, Rajwade JM, Omray P,
Khandelwal S and Paknikar KM: Silver
Nanoparticles in Therapeutics:
Development of an Antimicrobial Gel
Formulation for Topical Use, Mol.
Pharmaceutics 2009; 6 (5): 1388–1401.
22. Gurunathan S, Kalishwaralal K and
Vaidyanathan R: Biosynthesis, purif ication
and characterization of silver nanoparticles
Research Article ISSN: 2277-8713
Rayasa RM, IJPRBS, 2012; Volume 1(5): 160-177 IJPRBS
Available Online At www.ijprbs.com
using Escherichia coli, Colloid Surf B
Biointerfaces 2009; 74: 328–335.
23. Khlebtsov BN, Khanadeev VA and
Khlebtsov NG: Determination of the size,
concentration, and refractive index of silica
nanoparticles from turbidity spectra.,
Langmuir The Acs Journal Of Surfaces And
Colloids 2008; 24 (16): 8964-8970.
24. Liu X, Atwater M, Wang J and Huo Q:
Extinction coefficient of gold nanoparticles
with different sizes and different capping
ligands. Colloids and Surfaces B:
Biointerfaces 2007; 58(1): 3-7.
25. Moaddab S, Ahari H, Shahbazzadeh D,
Motallebi AA, Anvar AA, Rahman-Nya J and
Shokrgozar MR: Toxicity Study of Nanosilver
(Nanocid) on Osteoblast Cancer Cell Line.
Int Nano Lett. 2011; 1:11-16.
26. Babykutty S, Padikkala J, Sathiadevan
PP, Vijayakurup V, Karedath T, Azis A,
Srinivas P, and Gopala S: Apoptosis
Induction of Centella Asiatica on Human
Breast Cancer Cells, Afr J Tradit
Complement Altern Med. 2009; 6(1): 9–16.
27. Muthu IS, Selvaraj BM, Kalimuthu K and
Sangiliyandi G: Antitumor activity of silver
nanoparticles in Dalton’s lymphoma ascites
tumor model, Int J Nanomedicine 2010; 5:
753–762.
28. Sharma VK, Yngard RA and Lin Y: Silver
nanoparticles: green synthesis and their
antimicrobial activities. Advances in Colloid
and Interface Science 2009; 145: 83-96.
Thank you for copying data from http://www.arastirmax.com
